Invasive Pneumococcal Disease After Hematopoietic Cell Transplantation for Sickle Cell Disease
- 7 July 2026
- journal article
- Published by Wiley in Transplant Infectious Disease
- Vol. 28 (5) , e70271
Abstract
Background: Children with sickle cell disease (SCD) remain at risk for invasive pneumococcal disease (IPD) because of impaired splenic function and increased susceptibility to encapsulated bacteria. Data describing IPD after allogeneic hematopoietic cell transplantation (HCT) for SCD are limited. Methods: We conducted a multicenter retrospective cohort study of children and young adults with SCD undergoing first allogeneic HCT at two participating Sickle Cell Transplant Advocacy and Research (STAR) centers. IPD occurring within 365 days after HCT was identified through registry data, microbiologic culture review, and supplemental chart review. Results: Among 182 patients undergoing HCT, three developed IPD within the first year after transplant. All cases presented with sepsis and bacteremia; one patient also developed meningitis and died of septic shock. IPD occurred between 7 and 365 days after HCT. None of the patients had received post‐transplant pneumococcal vaccination before IPD diagnosis. Serotype data were unavailable for all cases. Conclusion: In this multicenter cohort of patients with SCD undergoing allogeneic HCT, IPD was uncommon but clinically severe, including late infections occurring nearly one year after transplantation. Prospective studies evaluating immune recovery, splenic function, pneumococcal vaccination practices, and long‐term infectious outcomes are needed to better define persistent susceptibility to invasive pneumococcal disease after HCT in patients with SCD. imageKeywords
Funding Information
- American Lebanese Syrian Associated Charities
This publication has 10 references indexed in Scilit:
- Clinical Effectiveness of Conjugate Pneumococcal Vaccination in Hematopoietic Stem Cell Transplantation RecipientsTransplantation and Cellular Therapy, 2020
- Risk of invasive pneumococcal disease in children with sickle cell disease in the era of conjugate vaccines: a systematic review of the literatureBritish Journal of Haematology, 2019
- Sickle Cell DiseaseNew England Journal of Medicine, 2017
- Invasive pneumococcal infections in children following transplantation in the pneumococcal conjugate vaccine eraTransplant Infectious Disease, 2016
- An overview of infectious complications after allogeneic hematopoietic stem cell transplantationJournal of Infection and Chemotherapy, 2016
- Improved Splenic Function After Hematopoietic Stem Cell Transplant for Sickle Cell DiseasePediatric Blood & Cancer, 2016
- 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised HostClinical Infectious Diseases, 2013
- Invasive Pneumococcal Disease Among Children With and Without Sickle Cell Disease in the United States, 1998 to 2009The Pediatric Infectious Disease Journal, 2013
- Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspectiveBone Marrow Transplantation, 2009
- Incidence of Invasive Pneumococcal Disease among Individuals with Sickle Cell Disease before and after the Introduction of the Pneumococcal Conjugate VaccineClinical Infectious Diseases, 2007